Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders (PRP)
Investigating Improvement of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Poor Responders
Sponsor: Genesis Athens Clinic
Listed as NCT03937661, this PHASE2/PHASE3 trial focuses on Infertility, Female and Ovary; Anomaly and remains actively recruiting participants. Sponsored by Genesis Athens Clinic, it has been updated 11 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Jan 2025 — Present [monthly]
Recruiting PHASE2/PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Mar 2023 — Jul 2024 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2022 — Mar 2023 [monthly]
Recruiting PHASE2_PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Jan 2022 [monthly]
Recruiting PHASE2_PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Oct 2019 — Aug 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Aug 2019 — Oct 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE2_PHASE3
First recorded
May 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Genesis Athens Clinic
- National and Kapodistrian University of Athens
For direct contact, visit the study record on ClinicalTrials.gov .